At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5 enrolled
Drug / intervention
Gene analysis +2 moregenetic
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Study of Gene Analysis and Treatment Optimization in Chinese Homozygous Familial Hypercholesterolemia
In Brief
An observational study evaluating Gene analysis, Historical data of lipid-lowering drug administration, and 1 other intervention for Homozygous Familial Hypercholesterolemia. Completed, enrolled 5 participants across 1 site.
Detailed Summary
Identify new or novel genes which may impact on cholesterol level, and establish the relationship between those gene mutations with atherosclerosis, as well as responses to lipid-lowering drugs.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHomozygous Familial Hypercholesterolemia
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2001
First PostedJun 2013
Primary CompletionOct 2014
Study CompletionJan 2015
TodayJul 2026
First PostedJun 17, 2013
Enrollment StartOct 1, 2001
Primary CompletionOct 1, 2014
Study CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 13 yearsPosted 13.0 years ago
Interventions
Gene analysisgenetic
Gene analysis
Historical data of lipid-lowering drug administrationother
Collecting historical data of lipid-lowering drug administration
Historical data of plasma lipids, xanthoma changesother
Collecting historical data of plasma lipids and xanthoma changes